Table 1.
Patient characteristics of the brachytherapy study population
| Factors | Number of patients (%) |
|---|---|
| Age, years | |
| Median: 61 | – |
| Range: 35-86 | – |
| Brachytherapy indication | |
| Initial diagnosisa | 33 (55%) |
| Stage I | 2 |
| Stage II | 11 |
| Stage III | 15 |
| Stage IV | 5 |
| Recurrent, previous radiationb | 21 (35%) |
| Recurrent, previous radiationc | 6 (10%) |
| Primary site | |
| Initial diagnosis | |
| Vagina | 20 |
| Cervix | 11 |
| Vulva | 2 |
| Recurrent, no previous radiation | |
| Uterus | 13 |
| Cervix | 4 |
| Ovary | 2 |
| Vulva | 2 |
| Recurrent, previous radiation | |
| Uterus | 3 |
| Cervix | 1 |
| Vulva | 1 |
| Rectum | 1 |
a
Initial diagnosis – BT as a component of primary treatment
b
Recurrent, no previous radiation – BT for recurrent disease in patients without prior pelvic radiation
c
Recurrent, previous radiation – BT for recurrent disease in patients who had previously received pelvic RT